High-dose Aflibercept: the PHOTON and PULSAR trials
Paolo Lanzetta, MD, and Jean-François Korobelnik, MD, PhD, speak about high-dose Aflibercept and th
LEARN MOREPaolo Lanzetta, MD, and Jean-François Korobelnik, MD, PhD, speak about high-dose Aflibercept and th
LEARN MOREProfessor Jean-François Korobelnik reviews the results at one year of the PHOTON and PULSAR studies
LEARN MOREData from a retrospective real world study highlights low incidence of proactive treatment of nAMD
LEARN MOREPersistent subretinal fluid associated with reduced risk of atrophy
LEARN MOREError